Suh, D.J.

therapy hepatitis hbeag lamivudine patient hbeag seroconversion relapse hepatitis b seroconversion study centre hepatitis b virus combination lamivudine therapy hbv dna virus analysis interferon ifn-lamivudine combination therapy antigen response serum alanine aminotransferase ifn therapy combination therapy durability baseline article hepatology pretreatment level hepatitis b infection trial lamivudine monotherapy treatment infection result factor monotherapy 0.4 multivariate analysis alanine group b c song limit aminotransferase pretreatment hbv dna asian b van nunen interferon alfa relapse rate cox regression log likelihood randomised eurohep regression ifn-lamivudine 0.03 post-treatment table 0.02 cox regression analysis asian race responder gut.bmj.com t cell response b e hansen effect erasmus mc cohort value netherland j suh cianciara j p value anti-hbe 16 weeks hbeag relapse rate likelihood november